✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Moderna Inc

Common Name
Moderna
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
5,800
Ticker
MRNA
Exchange
NASDAQ/NGS
Description
Moderna Inc. is a biotechnology company focused on developing transformative medicines based on messenger RNA (mRNA) technology. Its primary function is to research and produce a broad spectrum of vac...

Moderna's GHG Emissions Data Preview

In 2024, Moderna completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Moderna has also provided a category-level breakdown for 11 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Total Scope 2
Market-Based
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Location-Based
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Total Scope 3
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Limited Data Preview
You are viewing a limited preview of Moderna’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2021, and revenue-based intensity metrics for each scope.
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=MRNA&reporting_period=2024"

Verified Sources Behind Moderna’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Moderna’s data sources below and access millions more through our Disclosure Search.

a. Moderna's ESG Data Spreadsheet 2024

Insights into Moderna's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Moderna amounted to 30,883 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Moderna increased by 35.77%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Moderna's Scope 1 Emissions Over Time

202120222023202403.5 k7 k10.5 k14 ktCO2e+26%-3%+17%
  • Total Scope 1
  • Year-over-Year Change

What are Moderna's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Moderna were 13,180 metric tons of CO₂ equivalent (tCO₂e).a

Has Moderna reduced its Scope 1 emissions over time?

Since 2021, Moderna's Scope 1 emissions have increased by 44.17%, reflecting a rising long-term trend in Scope 1 emissions over time.a

Compared to the previous year (2023), Moderna's Scope 1 emissions increased by 17.26%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Moderna's Scope 2 emissions?

In 2024, Moderna reported Scope 2 greenhouse gas (GHG) emissions of 51 tCO₂e using the market-based method and 17,703 tCO₂e using the location-based method.a

Has Moderna reduced its Scope 2 emissions over time?

Since 2021, Moderna's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 118.04%, reflecting a rising long-term trend in Scope 2 emissions over time.a

Compared to the previous year (2023), Moderna's Scope 2 emissions (Location-Based) rose by 53.86% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does Moderna use for Scope 2 reporting?

In 2024, Moderna reported its Scope 2 emissions using the market-based method and using the location-based method.a

Moderna's Scope 2 Emissions Over Time

202120222023202404.5 k9 k13.5 k18 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Moderna's Value Chain Emissions

In 2024, Moderna reported 714,380 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of Moderna includes a breakdown across 11 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Moderna's Scope 3 Emissions Over Time

20212022202320240350 k700 k1.05 M1.4 MtCO2e+156%+7%-47%
  • Total Scope 3
  • Year-over-Year Change

What are Moderna's Scope 3 emissions?

In 2024, Moderna reported total Scope 3 emissions of 714,380 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 99.84% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.16% came from downstream activities like product use, distribution, and end-of-life treatment.a

Has Moderna reduced its Scope 3 emissions over time?

Since 2021, Moderna's Scope 3 emissions have increased by 45.7%, reflecting a rising long-term trend in Scope 3 emissions over time.a

Compared to the previous year (2023), Moderna's Scope 3 emissions decreased by 46.76%, highlighting the company's efforts to lower indirect emissions from its value chain.a

What categories of Scope 3 emissions does Moderna disclose?

In 2024, Moderna reported emissions for 11 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Moderna's Scope 3 emissions?

In 2024, the largest contributors to Moderna's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 561,984 tCO₂e (78.67%)
  • Capital Goods (Cat. 2): 93,389 tCO₂e (13.07%)
  • Upstream Transportation and Distribution (Cat. 4): 28,767 tCO₂e (4.03%)

Moderna's Scope 3 Emissions by Categories

Purchased Goods andServices (Cat. 1)(78.7%)Capital Goods(Cat. 2)(13.1%)UpstreamTransportation andDistribution(Cat. 4)(4.0%)

Insights into Moderna’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Moderna reported Scope 1 greenhouse gas (GHG) emissions of 13,180 tCO₂e and total revenues of USD 3,199 millions. This translates into an emissions intensity of 4.12 tCO₂e per millions USD.a

Moderna's Scope 1 Emissions Intensity Compared to Peers

2501,00010,000200,000Scope 1 Emissions (tCO2e)101005005,00050,000Revenues (Millions of USD)FRCIncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$MFFFortrea HoldingsYear: 2023Scope 1: 864 tCO2eRevenue: $M 3,109Scope 1 Intensity: 0.28 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MGuardant HealthYear: 2023Scope 1: 1,659 tCO2eRevenue: $M 564Scope 1 Intensity: 2.94 tCO2e/$MIlluminaYear: 2024Scope 1: 18,836 tCO2eRevenue: $M 4,372Scope 1 Intensity: 4.31 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MWatersYear: 2023Scope 1: 12,660 tCO2eRevenue: $M 2,956Scope 1 Intensity: 4.28 tCO2e/$MVeeva SystemsYear: 2024Scope 1: 264 tCO2eRevenue: $M 2,747Scope 1 Intensity: 0.10 tCO2e/$MRRRevvityYear: 2024Scope 1: 2,468 tCO2eRevenue: $M 2,755Scope 1 Intensity: 0.90 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MDexcomYear: 2024Scope 1: 8,328 tCO2eRevenue: $M 4,033Scope 1 Intensity: 2.07 tCO2e/$MCCCatalyst PharmaceuticalsYear: 2024Scope 1: 4 tCO2eRevenue: $M 493Scope 1 Intensity: 0.01 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MVertex PharmaceuticalsYear: 2024Scope 1: 8,976 tCO2eRevenue: $M 11,020Scope 1 Intensity: 0.81 tCO2e/$MModernaYear: 2024Scope 1: 13,180 tCO2eRevenue: $M 3,199Scope 1 Intensity: 4.12 tCO2e/$M

How does Moderna's GHG emissions intensity compare to its peers?

In 2024, Moderna reported a Scope 1 emissions intensity of 4.12 tCO₂e per millions USD. Compared to the peer group median of 2.26, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Moderna rank on GHG emissions intensity within its industry?

In 2024, Moderna ranked 16 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Moderna is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Insights into Moderna's Total Carbon Footprint

In 2024, Moderna reported a total carbon footprint of 745,263 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 45.38% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.a

The largest contributor to Moderna's total carbon footprint was Scope 3 emissions, accounting for 95.86% of the company's total carbon footprint, followed by Scope 2 emissions at 2.38%.a

Want Full Access to Moderna's GHG Emissions Dataset?
Sign Up